Samuel Denmeade is an Oncology physician affiliated with Johns Hopkins University. OpenAlex indexes 559 publications with 17,321 citations (h-index 64); ClinicalTrials.gov lists 12 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Baltimore, MD 212870005
Telephone
410-955-8964Registry record last updated 17 Jan 2014.
Clinical trials
- Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- The COSMYC Trial (COmbined Suppression of MYC)
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Exelixis Inc.Program year20241 payment
- MACROGENICS, INC.Program year20241 payment
- AstraZeneca Pharmaceuticals LPProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
7 NIH research awards on record, funded 2006–2026 per NIH RePORTER. The latest:
- Androgen Activation of Innate Immune Signaling to Enhance Prostate Cancer Immune Response
Johns Hopkins University
FY2026$495,606R01CA243184 - Project 1: Combined Suppression of MYC as therapy for CRPC: the COSMYC trial
Johns Hopkins University
FY2025$377,111P50CA272391
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”